De Greef G E, Van Staalduinen G J, Van Doorninck H, Van Tol M J, Hijmans W
Department of Pathology, Leiden University Hospital, The Netherlands.
Mech Ageing Dev. 1992;66(1):1-14. doi: 10.1016/0047-6374(92)90069-p.
The antigen-specific antibody secretion in vitro after immunisation with the primary T-cell dependent antigen Helix pomatia Haemocyanin (HPH) was investigated in both young and elderly individuals, who all met the health admission criteria for immunogerontological studies as detailed in the SENIEUR protocol. In addition, elderly non-Senieur persons were incorporated in this study. Young and elderly Senieur volunteers were fully comparable in terms of the occurrence of anti-HPH antibody secreting cells after in vitro simulation of peripheral blood mononuclear cells with variable doses of the antigen. In contrast, the non-Senieur elderly showed a lower number of anti-HPH antibody secreting cells in vitro. PHA-conditioned medium did enhance this in vitro response, whereas the addition of IL-2 remained ineffective. The PHA-induced T-cell proliferation was found to be somewhat impaired in elderly Senieur individuals and significantly lower in elderly non-Senieur individuals compared to young healthy persons. Using an immunofluorescence double staining technique after BrdU incorporation, the phenotype of the proliferating cells was determined. Again the total number of proliferating cells was impaired in the non-Senieur elderly. No changes in the relative contribution of CD4+ or CD8+ cells to the number of proliferating cells were found in the different age groups. On the other hand, a significantly lower number of proliferating cells with IL-2 receptor expression were detected in the non-Senieur individuals, which could account for the lack of response to IL-2 in this group. Our study clearly shows that so-called age-associated immune deficiency can be the result of disease and not necessarily of the ageing process itself.
使用原发性T细胞依赖性抗原——苹果蜗牛血蓝蛋白(HPH)对年轻和老年个体进行免疫后,研究其体外抗原特异性抗体分泌情况。这些个体均符合免疫老年学研究的健康纳入标准,如SENIEUR方案中详细所述。此外,本研究纳入了非SENIEUR方案标准的老年人。在体外使用不同剂量抗原模拟外周血单个核细胞后,年轻和老年SENIEUR志愿者在分泌抗HPH抗体细胞的出现情况方面完全可比。相比之下,非SENIEUR方案标准的老年人在体外分泌抗HPH抗体细胞的数量较少。PHA条件培养基确实增强了这种体外反应,而添加IL-2仍然无效。与年轻健康个体相比,发现PHA诱导的T细胞增殖在老年SENIEUR个体中有所受损,在非SENIEUR方案标准的老年个体中显著降低。在掺入BrdU后使用免疫荧光双染色技术,确定增殖细胞的表型。同样,非SENIEUR方案标准的老年人中增殖细胞的总数受损。在不同年龄组中,未发现CD4+或CD8+细胞对增殖细胞数量的相对贡献有变化。另一方面,在非SENIEUR方案标准的个体中检测到表达IL-2受体的增殖细胞数量显著减少,这可能解释了该组对IL-2缺乏反应的原因。我们的研究清楚地表明,所谓的年龄相关免疫缺陷可能是疾病的结果,而不一定是衰老过程本身的结果。